Phathom to Present at Three November Investor Conferences
Phathom Pharmaceuticals management will hold fireside chats and one-on-one meetings at three healthcare investor conferences in November 2026.
Updated on Nov. 4, 2026 in Public Companies
Phathom Pharmaceuticals management will take part in fireside chats and one-on-one meetings at the Guggenheim Healthcare Innovation Conference on November 10, the Stifel Healthcare Conference on November 11, and the Jefferies Global Healthcare Conference on November 18, 2026. Live webcasts will be available through the company's News & Events section.
Why it matters
The conference appearances give investors and analysts direct access to Phathom management as the company, which trades on Nasdaq under PHAT, commercializes its gastrointestinal treatments. Public webcasts widen access beyond the attendees of each event.
Phathom will appear at three conferences in November 2026, and recordings of each event will remain available for 90 days after it concludes. The announcement does not specify the content of the discussions.
The players
Phathom Pharmaceuticals
Phathom Pharmaceuticals is a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal diseases, and it trades on Nasdaq under the ticker PHAT.
The details
Management will join a fireside chat and one-on-one meetings at each conference, with the Guggenheim event held in Boston, the Stifel event in New York, and the Jefferies event in London. Company headquarters are in Florham Park, New Jersey, and the firm markets VOQUEZNA (vonoprazan) tablets in the United States under licensed rights for the U.S., Europe and Canada.
Timeline
November 10, 2026: Guggenheim Healthcare Innovation Conference fireside chat in Boston.
November 11, 2026: Stifel Healthcare Conference fireside chat in New York.
November 18, 2026: Jefferies Global Healthcare Conference fireside chat in London.
Market Landscape
Phathom's investor outreach is built around vonoprazan, a potassium-competitive acid blocker it licenses for the U.S., Europe and Canada and markets as VOQUEZNA. The company's pitch to investors rests on this single product line as it competes in the gastrointestinal treatment market.
Investors and analysts can follow the fireside chats through live webcasts or archived recordings available for 90 days after each event. The announcement itself contains no new product pricing, availability or financial changes for patients or consumers.
The takeaway
Investors who cannot attend the November conferences can access each fireside chat through the company's webcasts and recordings, which remain available for 90 days. Following the company's events page is the most direct way to track its investor presentations.
What happens next
Phathom management is scheduled to speak at the Guggenheim conference on November 10, the Stifel conference on November 11, and the Jefferies conference on November 18, 2026.
Further reading
Explore more Public Companies coverage for context on how listed firms engage with investors.
More information
Watch the live webcasts or archived recordings on the Phathom webcast and archived conference recordings page.
Source note: This article includes information reported by The Manila times.
